Document is current
Any future updates will be listed below
-
Authors
Blank, Norbert https://orcid.org/0000-0002-9419-1690
Kötter, Ina https://orcid.org/0000-0002-9262-005X
Schmalzing, Marc https://orcid.org/0000-0002-3289-2299
Rech, Jürgen https://orcid.org/0000-0002-2569-2029
Krause, Karoline https://orcid.org/0000-0001-9711-9654
Köhler, Birgit https://orcid.org/0000-0003-0098-7071
Kaudewitz, Dorothee https://orcid.org/0009-0004-2805-2643
Nitschke, Martin https://orcid.org/0000-0002-2716-7527
Haas, Christian S. https://orcid.org/0000-0003-2453-777X
Lorenz, Hanns-Martin https://orcid.org/0000-0003-0305-0946
Krusche, Martin https://orcid.org/0000-0002-0582-7790
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 1 August 2023
Accepted: 22 August 2023
First Online: 25 September 2023
Declarations
:
: NB and HML received research grants from SOBI and Novartis, and speaking honoraria from SOBI, Novartis, Roche, MSD, Abbott, Pfizer, Boehringer, Actelion and UCB. JR received research grants from SOBI and Novartis and speaking and consulting honoraria from Abbvie, Biogen, BMS, Chugai, GSK, Janssen, Lilly, MSD; Mylan, Novartis, Roche, Sanofi, Sobi, UCB. MK received lecture honoraria from SOBI, Novartis, Roche, Sanofi and Medac. IK, MS, KK, BK, DK, MN, CH declare that they have no competing interests.
: No previous preprint archiving was performed. No congress abstracts with content from this manuscript were published. No part of this manuscript was copied or published elsewhere in whole or in part in any language.
: This study reports on human data. Ethics approval was stated by the local ethics committee of the University of Heidelberg (reference S-103/2013). Each individual provided written informed consent as approved by the ethics committee (reference S-103/2013).
